UNC-School of Medicine: Two Popular Diabetes Drugs Outperform Two Others In Head-To-Head Comparison
September 23, 2022
September 23, 2022
CHAPEL HILL, North Carolina, Sept. 23 (TNSjou) -- The University of North Carolina School of Medicine issued the following news release:
* * *
The national GRADE study, with leadership and participation from UNC School of Medicine's John Buse, MD, PhD, and Sue Kirkman, MD, found that two of four common type 2 diabetes treatments -- glargine and liraglutide -- worked better than the other drugs, sitagliptin and glimepiride, to maintain blood glucose levels.
* * *
The national GRADE study, with leadership and participation from UNC School of Medicine's John Buse, MD, PhD, and Sue Kirkman, MD, found that two of four common type 2 diabetes treatments -- glargine and liraglutide -- worked better than the other drugs, sitagliptin and glimepiride, to maintain blood glucose levels.
